Results 51 to 60 of about 1,819,069 (310)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

LIVE 2010 Meeting Minutes [PDF]

open access: yes, 2010
This document is a compilation of LIVE (Low Input Viticulture & Enology) meeting minutes from 2010. Topics covered in the meeting minutes include Vinea (a Walla Walla sustainable group) and Salmon-Safe updates, creating the carbon mitigation ...
LIVE (Low Input Viticulture & Enology)
core   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Oregon Wine Board Meeting Minutes November 6, 2012 [PDF]

open access: yes, 2012
These meeting minutes list individuals in attendance and missing at the November 6, 2012 Oregon Wine Board (OWB) meeting, held at the offices of Davis Wright Tremaine in Portland, Oregon.
Oregon Wine Board
core   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Oregon Wine Board Meeting Minutes December 9, 2016 [PDF]

open access: yes, 2016
These meeting minutes list individuals in attendance at the December 9, 2016 Oregon Wine Board (OWB) meeting, held at the OSU Foundation Portland Center in Portland, Oregon. The Board went into Executive Session prior to calling the meeting to order. The
Oregon Wine Board
core   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Oregon Wine Board Meeting Minutes May 22, 2014 [PDF]

open access: yes, 2014
These meeting minutes list individuals in attendance and missing from the May 22, 2014 Oregon Wine Board (OWB) meeting, held at the Willamette Wharf Building in Portland, Oregon.
Oregon Wine Board
core   +1 more source

Home - About - Disclaimer - Privacy